Concourse Financial Group Securities’s Sigilon Therapeutics, Inc. Common Stock SGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Hold |
0
| – | – | – | 10675 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 10592 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 10216 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 10225 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 10036 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 9826 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 9587 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 9166 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8553 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8067 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 7649 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 7232 |
|